Sagamihara, Japan

Isao Okayasu


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Sagamihara-shi, Kanagawa, JP (2010)
  • Sagamihara, JP (2010 - 2011)
  • Kanagawa, JP (2014)

Company Filing History:


Years Active: 2010-2014

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Isao Okayasu: Innovator in Therapeutic Solutions

Introduction

Isao Okayasu is a notable inventor based in Sagamihara, Japan. He has made significant contributions to the field of medicine, particularly in developing therapeutic agents for conditions such as ulcerative colitis. With a total of 4 patents to his name, his work has the potential to impact patient care positively.

Latest Patents

One of Okayasu's latest patents is a therapeutic agent for ulcerative colitis. This invention provides a method for treating patients by administering a drug that contains an effective amount of tetracyclines. The drug may also include penicillins and/or metronidazoles. Another significant patent is a method for determining the stage of ulcerative colitis or interstitial pneumonitis, along with a reagent kit for this purpose. This invention allows for the easy discrimination of pathologic conditions and aids in selecting therapeutic drugs. It quantitatively judges stages by digitizing substances in urine, differing from conventional methods that require endoscopy or histological sample analysis.

Career Highlights

Throughout his career, Okayasu has worked with various companies, including Fujirebio Inc. His experience in the industry has allowed him to develop innovative solutions that address critical health issues.

Collaborations

Okayasu has collaborated with notable individuals in his field, including Mutsunori Fujiwara and Yuzo Hayashi. These partnerships have contributed to the advancement of his research and inventions.

Conclusion

Isao Okayasu's work exemplifies the spirit of innovation in the medical field. His patents and collaborations reflect a commitment to improving therapeutic options for patients suffering from ulcerative colitis and related conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…